Dr Suzanne Cutts, A/Prof Paul Pigram, Prof Geoff Pietersz, Dr Carleen Cullinane
La Trobe University
The purpose is to achieve tumour-specific delivery of a chemotherapy ‘drug activator’ in order to restrict cell kill by chemotherapy drugs to cancer tissues. Focus will be placed on obtaining a 'cancer specific nanoparticle’ to deliver these ‘drug activators’ to ensure that existing clinical drugs such as doxorubicin become more tumour selective.
Cancer specific nanoparticles for improved chemotherapy
Cancer Council Victoria Research Grant
$100,000 in 2013 and $95,902 pa in 2014 & 2015, nil in 2016